Drug Watch. Immune-mediated diseases--rheumatoid arthritis, psoriatic arthritis, psoriasis, and ankylosing spondylitis.
- Published in:
- Formulary, 2011, v. 46, n. 9, p. 397
- Publication type:
- Article
Works matching IS 1082801X AND DT 2011 AND VI 46 AND IP 9
Results: 14
1
2
Policy Watch. New user-fee renewal legislation will include new policies affecting reimbursement, research, regulatory oversight.
- Published in:
- Formulary, 2011, v. 46, n. 9, p. 395
- Publication type:
- Article
3
Longer-term use of pioglitazone associated with an increased risk of bladder cancer.
- Published in:
- Formulary, 2011, v. 46, n. 9, p. 394
- Publication type:
- Article
4
Repackaged Avastin causes eye infections in Florida.
- Published in:
- Formulary, 2011, v. 46, n. 9, p. 394
- Publication type:
- Article
5
Management of chronic obstructive pulmonary disease: An emphasis on recently approved medications and products in the pipeline.
- Published in:
- Formulary, 2011, v. 46, n. 9, p. 374
- By:
- Publication type:
- Article
6
Dronedarone increases risk of death and serious cardiac events in patients with permanent atrial fibrillation.
- Published in:
- Formulary, 2011, v. 46, n. 9, p. 373
- Publication type:
- Article
7
FDA reviews data regarding association between oral bisphosphonate therapy and esophageal cancer risk.
- Published in:
- Formulary, 2011, v. 46, n. 9, p. 373
- Publication type:
- Article
8
Boceprevir: A new oral protease inhibitor for the treatment of chronic hepatitis C.
- Published in:
- Formulary, 2011, v. 46, n. 9, p. 352
- By:
- Publication type:
- Article
9
Study assesses optimal method for communicating the absolute risks and benefits of drug therapy to patients.
- Published in:
- Formulary, 2011, v. 46, n. 9, p. 351
- Publication type:
- Article
10
Angiotensin receptor blockers not associated with an increased risk of cancer, FDA concludes.
- Published in:
- Formulary, 2011, v. 46, n. 9, p. 351
- Publication type:
- Article
11
FDA Drug Approvals. FDA actions in brief.
- Published in:
- Formulary, 2011, v. 46, n. 9, p. 350
- Publication type:
- Article
12
FDA Drug Approvals. First-time generic approvals.
- Published in:
- Formulary, 2011, v. 46, n. 9, p. 350
- Publication type:
- Article
13
FDA Drug Approvals. New molecular entities.
- Published in:
- Formulary, 2011, v. 46, n. 9, p. 349
- Publication type:
- Article
14
FDA Drug Approvals. Pipeline preview.
- Published in:
- Formulary, 2011, v. 46, n. 9, p. 349
- Publication type:
- Article